Stock Financial Ratios


CDXC / ChromaDex Corporation financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price6.90
Volume873,800.00
Market Cap ($M)283.44
Enterprise Value ($M)181.12
Book Value ($M)9.97
Book Value / Share0.27
Price / Book8.40
NCAV ($M)9.22
NCAV / Share0.25
Price / NCAV33.00
Income Statement (mra) ($M)
Revenue26.81
EBITDA-2.25
Net Income-2.93
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Assets17.05
Liabilities8.06
Quick Ratio0.70
Current Ratio1.59
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.29
Return on Assets (ROA)-0.16
Return on Equity (ROE)-0.29
Identifiers and Descriptors
CUSIP171077407
Central Index Key (CIK)1386570
Industry Groups
SIC 2833 - Medicinal Chemicals and Botanical Products
Other Related CUSIPS
171077957
171077100
Share Statistics
Common Shares Outstanding (M)48.19
Scoring Models
Piotroski F Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Property Plant And Equipment Per Share0.07
Cash And Equivalents Per Share0.00
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Liabilities Current Per Share0.19
Inventory Work In Progress Per Share0.00
Liabilities And Stock Equity Per Share1.12
Property Plant And Equipment Net Per Share0.07
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Cash Per Share0.00
Debt Per Share0.00
Accounts Receivable Per Share0.13
Inventory Raw Materials Per Share0.13
Liabilities Per Share0.22
Assets Current Per Share0.33
Assets Other Non Current Per Share0.00
Retained Earnings Per Share-1.28
Goodwill Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Additional Paid In Capital Per Share2.18
Assets Per Share0.46
Equity Per Share0.90
Minority Interest Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Inventory Per Share0.18
Intangibles Per Share0.05

Related News Stories

The Interesting Company That Produces An Anti-Aging Pill

2017-11-14 seekingalpha
ChromaDex has a product that can has multiple health benefits, including resistance to weight gain, improved control of blood sugar and cholesterol, reduced nerve damage, and longer lifespan. (79-0)

ChromaDex's (CDXC) CEO Frank Jaksch on Q3 2017 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Ladies and gentlemen, thank you for standing by, and welcome to the ChromaDex Corporation Third Quarter 2017 Earnings Conference Call. My name is Brian, and I will be the conference operator today. [Operator Instructions]. (6-0)

Billionaires Club Investing In ChromaDex As Revenue Grows

2017-11-10 seekingalpha
Recent change in company strategy includes sale of their lab business and more focus on Niagen (NR) sales. (147-1)

BRIEF-Chromadex announces $23 mln private placement of common stock

2017-11-06 reuters
* Chromadex Corp - in connection with investment, co agreed to sell 5.6 million shares of common stock at a per share price of $4.10​ (6-1)

BRIEF-Chromadex Corp files for common stock‍​ offering by selling stockholders of up to $7.7 mln

2017-10-31 reuters
* Chromadex Corp files for common stock‍​ offering by selling stockholders of up to $7.7 million - SEC filing Source text: [bit.ly/2z2cq3P] Further company coverage: (6-0)

CUSIP: 171077407